Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $18.8600 (2.25%) ($18.8600 - $18.8600) on Mon. Feb. 1, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.12% (three month average) | RSI | 40 | Latest Price | $18.8600(2.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -0.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.06% in a week (0% probabilities). VIXM(-34%) VXX(-27%) UNG(-10%) UUP(-9%) TLT(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.06% (StdDev 4.12%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $19.09 | 5 Day Moving Average | $18.94(-0.42%) | 10 Day Moving Average | $18.8(0.32%) | 20 Day Moving Average | $19.09(-1.2%) | To recent high | -28.3% | To recent low | 48.7% | Market Cap | $1.401b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |